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The  research  work  in  this  thesis  entitled  “Formal  Synthesis  of 
Furanodictines,   (-)-Varitriol and Development of Novel Synthetic Processes, 
Methodologies for Biologically Active Compounds” has been undertaken with 
an  objective  to  synthesize  biologically  active  carbohydrate  based  natural 
products.  Further,  the other aim was to develop new synthetic  processes and 
methodologies for molecules of biological significance. 
The thesis is divided into four chapters; Chapter-1 describes the formal 
synthesis of furanodictines A and B from the cheap starting material  D-glucose. 
The chapter- 2 deals with total synthesis of (-) varitriol and aromatic metabolite 
RKB 3564S. The Chapter-3 describes the development of new synthetic processes 
for  molecules  of  biological  significance  such  as  the  sucralose  (artificial 
sweetener), allolactose (lac operon inducer) and myristicinaldehyde. This chapter 
is divided in to three sections. The final chapter deals with the development of 
synthetic  methodologies  for  biologically  active  benzoxanthenes  and 
amidonapthols  by  recyclable  solid  acid  catalyst,  tungstated  zirconia  and 
potassium dodecatungstocobaltate trihydrate. This chapter is divided in to two 
sections.
 Chapter I : Formal synthesis of aminosugars, furanodictine A and B from D-
glucose
Many  interesting  and  structurally  diverse  carbohydrates  are 
components of biologically active natural products. Recently, the amino sugars 
furanodictines B (1a) and A (1b) were  isolated from slime molds Dictyostelium 
discoideum with absolute  configurations  of  (2R,3R,4S,5R)  and  (2S,3R,4S,5R), 
respectively.  They exhibits potent neuronal differentiation activity and are the 
lead structures in the development of novel nerve-rejuvenation drugs. Further, 
the  core bicyclic bis-tetrahydrofuraofuran structures also constitute an integral 
part  of  several  other  natural  products.  We  have  developed  a  new  synthetic 
12
approach for asymmetric synthesis of 1a and 1b using commercially available D- 
glucose. 
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Retrosynthetic analysis:
The retrosynthetic analysis of Furanidictine B (1a) has indicated that the 
absolute configurations at C(4), C(5) and C(6) are the same as those present in D-
glucose at C(3), C(4) and C(5), respectively. The stereocentre at C(3) of 1b can be 
derived by nucleophilic inversion (SN2) of configuration at C(2) of D-glucose by 
azide.  The  bicyclic  3,6-anhydro  sugar  3  can  be  constructed  through  the 
intramolecular  cyclization  of  the  C(3)  hydroxyl  group  with  C(6)  by  a  simple 
protocol developed earlier by us . Similarly furanodictine-A, compound 1b can 
be obtained from D-glucose by overall retention of configuration at C (3) carbon. 
Execution of the retrosynthetic plan is summarized in (Scheme 1). 
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Furanodictine B:
The key intermediate  2 in  the synthesis  of  furanodictine A and B was 
prepared from  D-glucose. The synthetic strategy started with  acetonation of  D-
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glucose  to 1,2:5,6-di-O-isopropylidene-α-D-glucofuranoside,  followed  by 
controlled  hydrolysis  in  which  5,6-O-isopropylidene  group  is  selectively 
deprotected  to give the triol, 2-O-isopropylidene-α-D-glucofuranoside 4  (mono 
acetone glucose). The 3,6-anhydro sugar derivative 6 was synthesized by treating 
glucofuranose  4  with  diethylcarbonate  and  sodium  hydride  followed  by 
benzylation with benzyl bromide. The bicyclic benzylic ether 6 on methanolysis 
catalyzed by ion exchange resin IR-120 H+ gave the 2-hydroxy derivative 7 as a 
diastereomeric mixture (anomeric ratio α/β = 2:3). The 2-hydroxy derivative of 
anhydro sugar  7,  was transformed to the key intermediate  2  on reaction with 
triflic anhydride and pyridine (Scheme 2). 
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Scheme 2: Reagents and conditions: i) Acetone, H2SO4, rt; ii) 0.8% H2SO4, aq. MeOH rt; iii) 
Diethyl carbonate, sodium hydride; iv) BnBr, NaH, DMF; v) IR 120-H+, MeOH, reflux, 2 
h; vi) Tf2O, pyridine, 0 °C to rt, 1 h; vii) NaN3, DMF, 60 °C, 6 h; viii) Ph3P, THF–CH2Cl2, 
rt, 3h; xi)Ac2O, pyridine, CH2Cl2, rt, 2 h; x) Pd(OH)2/C/H2, MeOH, 1atm, 2 h.
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The key intermediate  2 on nucleophilic displacement (SN2) with sodium 
azide afforded the azido derivative 8 which was characterized by IR peak at 2130 
cm-1.  The  reduction  of  the  azido  derivative  8 was  achieved  with  triphenyl 
phosphine followed by acetylated with acetic anhydride in pyridine to give  N-
acylated compound  9.  The acetamide  9 was subjected to hydrogenolysis using 
palladium hydroxide at  atmospheric  pressure  to  provide the required methyl 
3,6-anhydro-N-acetylamino β-D-mannofuranoside  10 as a crystalline solid (mp 
174– 175 °C). The crystalline solid 10 was characterized by  1H NMR spectrum 
from the appearance of H-1 at δ 4.97 as a doublet (J = 2.3 Hz), methoxy group at 
δ 3.36 and acetyl group at δ 2.01. The advanced intermediate 10 was obtained in 
13.2%  overall  yield  from  D-glucose.  The  conversion  of  compound  10 to  the 
natural product FD-B has been reported earlier there by completing the formal 
synthesis of furanodictine B 1a. 
Synthesis of Furanodictine A :
In the synthesis  of furanodictine A, the key intermediate  2 prepared from  D-
glucose was utilized. A stereospecific inversion at C 2 position of intermediate 2 
was successfully carried out with triflic anhydride and cesium trifluoroacetate to 
give  an  alcohol  11.  The  alcohol  was  converted  to  corresponding  2-O-triflate 
derivative  12  on  reaction  with  triflic  anhydride  in  presence  of  pyridine  in 
quantitative  yield.  The  nucleophilic  displacement  (SN2)  reaction  of  12 with 
sodium  azide  smoothly  afforded  the  azido  derivative  13  with  inversion  of 
configuration. The azide functionality was reduced with triphenyl phosphine to 
afford  amine  14,  which  was  acetylated  with  acetic  anhydride  in  pyridine  to 
afford  N-acetylated  amine  15.  Finally,  the  benzyl  group  was  deprotected  by 
hydrogenolysis using palladium hydroxide to provide the required methyl 3, 6-
anhydro-N-acetylamino β-D-glucofuranoside  16.  The advanced intermediate  16 
can be converted to the furanodictine A 1b in two steps, thereby completing the 
total synthesis of the target compound.
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Scheme 3:  Reagents and conditions: i) CsOCOCF3; ii) Tf2O, pyridine,0 °C to rt, 1 h; iii) 
NaN3, DMF, 60 °C, 6 h; iv) Ph3P, THF-CH2Cl2, rt, 3 h; v) Ac2O, pyridine,CH2Cl2, rt, 2 h; 
vi) Pd(OH)2/C/H2, MeOH, 1atm, 2 h.
 In this chapter,  a  simple and efficient  route for the formal total  synthesis  of 
furanodictine B and furanodictine A has been developed starting from cheap and 
readily available raw material D-glucose.
Chapter II: Synthesis  of  (-)-varitriol  and  development  of  new  synthetic 
routes to RKB 3564S.
Marine-derived  biologically  active  natural  products  continue  to  be  a 
source of potential therapeutic compounds as well as motivation to develop new 
synthetic  strategies  for their  construction.  (+)-Varitriol  17 was isolated from a 
marine-derived  strain  of  the  fungus  Emericella  variecolor and  its  exhibits 
significant cytotoxic activity against renal, CNS and breast cancer cell lines. RKB 
3564S 18 is an aromatic metabolite of a fungal strain of the Acremonium sp. (MST-
MF558a) and known for its antitumor and antiangiogenesis activity. Further, it 
was  patented for  the treatment  of  diabetes,  obesity,  and neuroses,  as  well  as 
Alzheimer’s and Parkinson’s diseases.
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In  the  present  work,  the  total  convergent  synthesis  of  (-)-varitriol  by 
synthesizing the aromatic fragment in a new route and the synthetic approach to 
the carbohydrate fragment from D-ribose is described. 
Retrosynthetic analysis:
The retrosynthetic analysis of varitriol is delineated in Scheme 4. The aromatic 
fragment can be obtained from substituted phenol 19. The bottom carbohydrate 
portion of varitriol can be derived from D-ribose due to the similarities between 
the bottom portion of varitriol and the natural carbohydrate D-ribose. 
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The furanoside 22 serves this purpose quite well with two orthogonal aldehyde 
surrogates present as a protected primary alcohol and a nitrile functional group. 
Thus, the β-C-furanoside subunit 20 could readily be derived from the aminal 21, 
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which in turn would originate from the ‘‘pseudo’’ C2 symmetric compound 22. 
We envisaged the final key convergence of the styrene derivative  18 with the 
furanoside 20 via an olefin cross-metathesis reaction.
 Synthesis of aromatic fragment (styrene):
In the synthesis of aromatic fragment 18, the substituted benzaldehyde 25 
was  the  key  intermediate  and  synthesized  from  commercially  available  2,  3 
dimethyl  phenol  19 as  depicted  in  Scheme 5.  The substituted phenol  19  was 
protected  as  methyl  ether  23 by  methyl  iodide,  followed  by  free  radical 
bromination with N-bromosuccinimide to provide tribrominated compound 24. 
The acetolysis of the tri brominated compound 24 with sodium acetate provided 
substituted benzaldehyde 25. 
The key intermediate  25 on single carbon Wittig olefination with methyl 
triphenyl phosphonium iodide gave the aromatic intermediate 26. The reduction 
of  ester  moiety  in  26 under  basic  medium  provided  corresponding  benzylic 
alcohol compound  27, which on protection as silyl ether by treating with  tert-
butyldimethylsilyl chloride afforded the aromatic fragment  18.  The substituted 
styrene 18 was characterized by 1H NMR spectrum with the appearance of OTBS 
peak at δ 0.11 (s, 6H), 0.95 (s, 9H), and values were in complete agreement with 
that reported in literature.
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Scheme  5: Reagents  and  conditions: i)  CH3I,  Aq.  KOH,  TBAH,  CH2Cl2 ii)  NBS,  CCl4, 
reflux,hv.  iii)  NaOAc,  CH3COOH iv)  CH2=PPh3I,  THF,  rt.  v)  NaOMe/MeOH, rt.  vi) 
TBSCl/imidazole, DMF, rt.
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Synthesis of carbohydrate fragment:
The synthesis of carbohydrate fragment, β-C-furanoside subunit 20 started 
with  D-ribose  28  which was converted  to  a  valuable  intermediate  1-O-acetyl-
2,3,5-tri-O-benzoyl-β-D-ribose  29  (Scheme  6). The  protected  ribose  29 was 
converted to cyanosugar  30 by anchimeric  assisted nucleophilic  addition of  a 
cyanide anion via trimethylsilyl cyanide to the  in situ generated oxocarbenium 
cation derived from  29.  The selective deprotection of benzoate  with saturated 
methanolic ammonia gave syn-diol,  which was reprotected as acetonide with 2, 
2-dimethylpropane to afford the intermediate 22. 
The  key  intermediate  22 on  reduction  of  the  nitrile  functionality  with 
Raney  nickel  coupled  with  N,N’-diphenylethylenediamine  furnished  the 
corresponding  aminal  31.  The  benzoate  ester  in  aminal  31 was  removed  by 
sodium  methoxide  in  methanol,  followed  by  tosylation  of  the  free  primary 
hydroxyl  moiety  with  tosyl  chloride  in  dry  pyridine  to  provide  the 
corresponding tosylate 32.  The reduction of tosylate 32 with Lithium aluminium 
hydride provided the protected aminal 33. Finally, the removal of the aminal in 
33 by  para-toluene sulphonic acid furnished aldehyde,  which without isolation 
was  subjected  to  olefination  with  one  carbon  Wittig  reagent  allowed  the 
formation of the desired β-C-furanoside  20. The carbohydrate fragment  20 was 
characterized from its 1H NMR by the appearance of peaks at 5.18 (d, 1H, J = 10.9 
Hz), 5.34 (d, 1H, J = 17.4 Hz).
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Scheme 6: Reagents and conditions: (i) TMSCN, SnCl4,  CH2Cl2, rt, 3 min; (ii) NH3, MeOH, 
0 °C, 4.5 h; (iii) DMP, HClO4, acetone, rt, 2 h; (iv) Raney nickel, NaH2PO2,  N,N’-DPED, 
HOAc–pyridine– H2O (1:2:1), rt, 1 h; (v) NaOMe, MeOH, rt; (vi) TsCl, pyridine, 0 °C to 
rt, 24 h; (vii) LiAlH4, THF, 0 °C-rt, 3 h; (viii) PTSA, acetone, CH2Cl2, at 0 °C then rt, 1 h; 
(ix) tBuOK, methyltriphenylphosphonium iodide, ether, 12 h. 
The final cross metathesis of aromatic and carbohydrate fragments (18 and 
20)  in  presence  of  Grubbs’  second-generation  carbene  catalyst provided  the 
protected natural product 34, which on deprotection with 1M hydrochloric acid 
afforded (-)-varitriol  17  (Scheme 7). The formation of  17  is evident from its  1H 
NMR spectrum by appearance of characteristic olefin peaks at δ 6.20 (dd, 1H, J = 
15.8, 6.6), 6.89 (d, 1H, J = 8.0).
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Scheme 7: Reagents and conditions: (i) Grubbs 2nd generation catalyst (5 mol%), CH2Cl2, 
reflux, 18 h; (ii) 1 M HCl, THF, rt, 2 h.
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Synthesis of aromatic metabolite RKB 3564S: 
The aromatic metabolite  RKB 3564S  (37)  with varied biological activity 
has  structural  similarity  to  varitriol.  The  common  intermediate  25 in  the 
synthesis of aromatic fragment of varitriol was used as a starting material, which 
was obtained from sequential etherification, radical bromination and acetolysis 
starting with 2, 3-dimethyl phenol  19  (Scheme 8). The benzaldehyde derivative 
25 was subjected to two- carbon Wittig olefination, followed by deacetylation 
using sodium methoxide to provid the benzylic alcohol 36. Finally, the benzylic 
alcohol derivative 36 was subjected to demethylation using boron tribromide to 
afford the target compound RKB 3564S. It was characterized from the 1H NMR 
by the disappearance of corresponding methoxy peak at δ 3.86 and the other 
values were in agreement with that reported in literature.
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Scheme 8: Reagents and conditions: i) CH3I, AqKOH, TBAH, CH2Cl2; ii) NBS, CCl4, reflux; 
iii)  NaOAc,  CH3COOH; iv)  CH3CH2=PPh3I,  THF,  rt;  v)  NaOMe/MeOH,  rt;  vi)  BBr3, 
CH2Cl2, rt.
In  conclusion,  we  have  completed  a  convergent  total  synthesis  of  (-)-
varitriol  from  D-ribose  and  2,  3-dimethyl  phenol  as  well  as  the  synthesis  of 
aromatic metabolite RKB 3564S.
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Chapter III:  Development of novel synthetic processes for biologically active 
compounds.
Section A: Synthesis  and  process  for  the  preparation  of  4,1’,6’-trichloro 
-4,1’6’trideoxy galasctosucrose. (Sucralose)
Sucralose  (42)  is  a  chlorinated disaccharide  and  a  zero-calorie  artificial 
sweetener sold under the brand names Splenda and SucraPlus.  It is about 600 
times as sweet as sugar and used in various food and beverage products. Most of 
the  earlier  approaches  to  sucralose  synthesis  require  five  steps  of  organic 
transformation and therefore a limitation in the development of efficient process. 
In  view of  this,  we  have  developed  and  improved  the  process  for  sucralose 
preparation by carrying out it in four steps. 
The feasible synthesis was successfully attempted using sucrose as a raw 
material (Scheme 9).  The primary and secondary hydroxyl groups of sucrose 38 
were  selectively  protected  to  give  tri-O-trityl  penta-O-acetyl  sucrose  in 
quantitative yield. The detritylation of the protected sucrose 39 was carried out 
with 5% trifluoro acetic anhydride in dichloromethane at room temperature in 
order to obtain 2,3,4,3’,4’-penta-O-acetyl sucrose.  However,  we found that the 
use of TFA for the deprotection of trityl group also effected the migration of 
acetyl  group  from  secondary  to  primary  position.  This  improved  one-pot 
deprotection-rearrangement reaction provided the intermediate 2,3,6,3’,4’-penta-
O-acetyl sucrose 40. Moreover, this one-pot reaction avoids the use of acetic acid 
in  boiling  conditions  and  tedious  workup  of  purification  as  mentioned  in 
literature. 
The intermediate 40 was transformed to tri chlorinated compound 4, 1’, 6’-
trichloro-4,1’,6’-trideoxygalactosucrose penta-acetate  41 by reaction with carbon 
tetrachloride  as  chlorinating  agent  in  the  presence  of  triphenylphosphine   in 
good yield. Finally, the derivative 41 was subjected to deacetylation with sodium 
methoxide  in  methanol  to  give  a  target  compound  4,1’,6’-trichloro-4,1’,6’-
trideoxygalactosucrose  42 (sucralose)  in  80%  yield.  The  formation  of  target 
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compound 42 was characterized from 1HNMR by disappearance of acetate peaks 
at δ 2.00-1.09 and the other peaks were in complete agreement with literature 
values. 
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cheme 9: Reagents and conditions: i) Trityl chloride, pyridine, 40 °C; Ac2O, rt; ii) Trifluoro 
acetic acid, CH2Cl2, rt; iii) CCl4, pyridine, imidazole;  iv) NaOAc, MeOH.
In  conclusion in this  section an efficient  process for  the preparation of 
sucralose is described. The key step is the one pot reaction in which deprotection 
and rearrangement by acyl migration takes place. In the other synthetic steps, the 
overall  yields  were  improved  and  the  reactions  carried  out  under  milder 
conditions.
Section B:  Synthesis of β-D-Galactopyranosyl (1→6)-D-glucose (allolactose).  
Allolactose,  the  isomer  of  lactose,  plays  an  important  role  in  bacterial 
metabolism  by  acting  as  inducer  of  the  lac  operon.  It  is  not  available 
commercially and most of the approaches are based on the use of enzymes. In 
23
continuation to  our research  on disaccharides  we are interested to synthesize 
allolactose in an economical route.
In the present section, allolactose was synthesized from galactose bromide 
and glucose tetraacetate employing Koenigs Knorr reaction for galactosylation. 
The bromo galactose 43 was prepared from D-galactose, whereas glucose 1, 2, 3, 4 
tetra acetate 44 was obtained from from D-glucose. The galactosylation of 43 and 
44 using silver carbonate provided acetyl derivative of allolactose 45,  which on 
deacetylation with ion-exchange basic resin (IR 400 OH-  Amberlite) provided the 
target compound 46 (Scheme 10). 
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Scheme 10. Reagents and conditions: i) (MeCO)2O/HClO4, P/Br2/H2O; ii) Trityl chloride, 
pyridine, acetic anhydride, 60 °C. iii) HBr in CH3COOH; iv) Ag2CO3, CHCl3, rt; v) IRA-
400 resin (OH)- form.
In  the  present  section,  a  facile  and  economical  synthetic  route  for  the 
synthesis of allolactose is described. The key step of glycosidation was carried 
out by celite supported silver carbonate in improved yields. The reusable ion-
exchange  basic  resin  was  used  for  the  deprotection  of  acetyl  groups  in 
quantitative yield. The synthesized allolactose is under investigation for  DNA 
binding studies and preliminary results are encouraging.
Section C: A facile synthetic route to myristicinaldehyde.
Myristicinaldehyde  is  the  key  component  in  the  synthesis  of  some 
alkaloids such as nascopine, which is helpful in suppression of cough and used 
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as intermediate for synthesis of other natural products.  Further, it is used in the 
design  and  structural  activity  relationship  studies  of  new  anti-cancer  agents 
especially combrestatins analogues and arylethylamine psychotropic recreational 
drugs. The methods used in the preparation of these key compound 50 reported 
in  literature,  make  use  of  hazardous  chemical  reagents,  tedious  workup and 
purification  procedures.  So,  we  have  planned  a  new  synthetic  route  to 
myristicinaldehyde  which  devoid  of  use  of  hazardous  reagents,  particularly 
bromine and tedious purification procedures. 
In the present synthetic route, the cheap starting material vanillin  47  on 
Vilsmayer formylation provided the dialdehyde 48, which upon treatment with 
3% hydrogen peroxide in 1N NaOH solution provided the substituted catechol, 
3,4-dihydroxy-5-methoxy  benzaldehyde  49  in  good  yield.  Finally,  the 
methylenation  of  substituted  catechol  using  methylene  chloride  provided 
myristicin aldehyde  50  in good yields. The formation of target compound was 
characterized  from  its  melting  point  (131  °C)  and  1HNMR  spectrum  by 
appearance of peaks as methylene protons at δ 6.12 (s, 2H) and aromatic protons 
at δ 7.00 and 7.10 (2s, 2H).
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Scheme 11 Reagents and conditions: i) Hexamine, acetic acid, 60 °C; (ii) H2O2, rt; iii) 50% 
aq. NaOH, DMSO, CH2Cl2.
  In literature the myristicinaldehyde has been used in the synthesis of 
cotarnine 51. In addition to this, alternative route to myristicinaldehyde starting 
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from trimethoxy benzaldehyde was also attempted. In conclusion, in the present 
synthetic route, the use of hazardous bromine is avoided with improved yields.
Chapter IV: Synthesis  of  benzoxanthenes  and substituted amido naphthols 
by recylable solid acid catalysts
 Section  A:  Efficient  synthesis  of  aryl-14H-dibenzo[a.j]xanthenes  employing 
tungstated zirconia as  heterogeneous catalysts in solvent free media.
Benzoxanthenes has emerged as a attractive scaffold in organic synthesis 
due to their biological and therapeutic properties such as antibacterial, antiviral, 
and anti-inflammatory activities. Furthermore due to their useful spectroscopic 
properties,  they  are  used  as  dyes,  in  laser  technologies,  and  in  fluorescent 
materials for visualization of biomolecules. Even though various procedures are 
reported, disadvantages including low yields, prolonged reaction times, use of 
an excess of reagents /catalysts and use of toxic organic solvents necessitate the 
development of an alternative route for the synthesis of xanthenes derivatives. In 
this  pursuit  a  simpler  and  greener  protocol  has  been  developed  for  the 
preparation of aryl-14H-dibenzo[a.j]xanthenes by a one-pot condensation of β-
naphthol  and  aryl  aldehydes,  in  the  presence  of  tungstated  zirconia 
(5%WO3/ZrO2)  as  heterogeneous catalysts.  The reactions were investigated in 
solvent-free  conditions  under  conventional  heating  (125  °C)  as  well  as 
microwave conditions.
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Scheme 12 Reagents and conditions: 5% WO3/ZrO2, Neat 125 °C or microwave
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The  present  methodology  for  the  synthesis  of  benzoxanthenes  offers  several 
advantages such as excellent yields (80-96 %), simple procedure, short reaction 
times (2-8 h) and milder conditions. Further, the recyclability of the catalyst was 
investigated and good conversions were observed after successive operations.
Section B:  Potassium dodecatungstocobaltate trihydrate: A mild and efficient 
reusable catalyst  for the synthesis of amidoalkyl naphthols  in solution and 
under solvent-free conditions.
An efficient and direct procedure has been developed for the preparation 
of  amidoalkyl  naphthols  by  a  one-pot  condensation  of  aryl  aldehydes,  β-
naphthol  and  urea  or  amides,  in  the  presence  of  potassium 
dodecatungstocobaltate  trihydrate  [K5CoW12O40.3H2O,(1  mol%)]  as  a 
heterogeneous catalyst. The reactions were carried out in 1,2-dichloroethane at 
room  temperature  or  under  solvent-free  media  at  elevated  temperature.  The 
present methodology offers several advantages such as excellent yields ranging 
from 90-96%, simple procedure and the catalyst exhibited remarkable reusability.
R1 = H, 4-Br,  4-Cl, 3-Cl, 2,2-Cl,  , 3-NO2,  3-OCH3,  4-CH3
OH
+
CHO
+ RCONH2
OH
NHCOR
57
565553
K5CoW12O40.3H2OR1
(1 mol%)
R = CH3, NH2
R1
Scheme  13  Reagents  and  conditions:  K5CoW12O40.3H2O,  EDC,  rt  (or)  neat  (or) 
microwave
The recyclability  of  the catalyst  was  investigated and good conversions  were 
observed after successive operations.
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